Icon

Strategic partnerships: a good deal for CROs, or just a cost-cutting measure by big pharma?

Monday, June 13, 2011 08:01 AM

Strategic partnerships with the top 20 pharma companies are what most sizable CROs dream of these days.

More... »


Pfizer chooses Icon and Parexel as its two strategic outsourcing partners in 5-year deals

Monday, June 6, 2011 10:23 AM

Strategic partnerships with large pharma recently have become the holy grail among CROs. And two have been awarded by Pfizer, the largest drug maker in the world.

More... »


Icon's central labs launches cytometry services

Thursday, May 26, 2011 02:31 PM

The central laboratories arm of Ireland-based global CRO Icon has launched a global cytometry services offering through its facilities in New York, Dublin, Bangalore and Singapore, according to PharmaTimes.

More... »

Pfizer strategically partners with Icon, Parexel

Thursday, May 26, 2011 11:53 AM

Pfizer today doled out two large strategic partnership agreements, which have become the brass ring for which most CROs medium and large are jockeying.

More... »

ICON partners with Boston Clinical Research Institute

Friday, May 13, 2011 11:25 AM

Global CRO ICON, based in Ireland, is widening its access to key opinion leader expertise and clinical investigators, both in the U.S. and worldwide, through an alliance with Boston Clinical Research Institute (BCRI), according to PharmaTimes.

More... »

The CenterWatch Monthly, May 2011

Monday, May 2, 2011 11:05 AM

Sites worldwide rate PPD, Kendle, ICON top CROs

More... »

Harlan names Manuela Leone president, CRS

Wednesday, April 27, 2011 12:01 PM

Global CRO Harlan Laboratories has appointed Dr. Manuela Leone as president of contract research services (CRS) for the company.

More... »

Icon and Acronet sign alliance agreement

Monday, April 25, 2011 12:15 PM

Ireland-based Icon,a global CRO for the pharmaceutical, biotechnology and medical device industries, and Japan-based CRO Acronet, have signed an alliance agreement. The two companies will collaborate to offer global and Japanese pharmaceutical clients a range of clinical development capabilities to manage trials, regionally and globally.

More... »

Chiltern, Icon expand offices

Thursday, March 31, 2011 12:19 PM

Two global CROs, Chiltern International and Icon, have extended their operations in Europe and the Asia Pacific region respectively with new offices in the Netherlands and China, according to PharmaTimes.

More... »

Lexicon Pharmaceuticals names Dr. Pablo Lapuerta CMO

Tuesday, March 29, 2011 12:15 PM

Lexicon Pharmaceuticals has named Pablo Lapuerta, M.D., chief medical officer. He will be responsible for directing clinical development of Lexicon's drug candidates from phase II proof-of-concept through phase III and approval.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs